Functional gap junctions facilitate melanoma antigen transfer and cross-presentation between human dendritic cells. 2007

Ariadna Mendoza-Naranjo, and Pablo J Saéz, and C Christian Johansson, and Marcos Ramírez, and Dinka Mandakovic, and Cristian Pereda, and Mercedes N López, and Rolf Kiessling, and Juan C Sáez, and Flavio Salazar-Onfray
Disciplinary Program of Immunology, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Santiago, Chile.

Previously, we found that human dendritic cells (hDCs) pulsed with a melanoma cell lysate (MCL) and stimulated with TNF-alpha (MCL/TNF) acquire a mature phenotype in vitro and are able to trigger tumor-specific immune responses when they are used in melanoma immunotherapy in patients. In this study, we describe that MCL/TNF induces gap junction (GJ)-mediated intercellular communications and promotes melanoma Ag transfer between ex vivo produced hDCs from melanoma patients. hDCs also exhibit increased expression of the GJ-related protein connexin 43, which contributes to GJ plaque formation after MCL/TNF stimulation. The addition of GJ inhibitors suppresses intercellular tumor Ag transfer between hDCs, thus reducing melanoma-specific T cell activation. In summary, we demonstrate that MCL/TNF-stimulated hDCs can establish functional GJ channels that participate in melanoma Ag transfer, facilitating Ag cross-presentation and an effective dendritic cell-mediated melanoma-specific T cell response. These results suggest that GJs formed between hDCs used in cancer vaccination protocols could be essentials for the establishment of a more efficient antitumor response.

UI MeSH Term Description Entries
D007546 Isoquinolines A group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed)
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D002450 Cell Communication Any of several ways in which living cells of an organism communicate with one another, whether by direct contact between cells or by means of chemical signals carried by neurotransmitter substances, hormones, and cyclic AMP. Cell Interaction,Cell-to-Cell Interaction,Cell Communications,Cell Interactions,Cell to Cell Interaction,Cell-to-Cell Interactions,Communication, Cell,Communications, Cell,Interaction, Cell,Interaction, Cell-to-Cell,Interactions, Cell,Interactions, Cell-to-Cell
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D003713 Dendritic Cells Specialized cells of the hematopoietic system that have branch-like extensions. They are found throughout the lymphatic system, and in non-lymphoid tissues such as SKIN and the epithelia of the intestinal, respiratory, and reproductive tracts. They trap and process ANTIGENS, and present them to T-CELLS, thereby stimulating CELL-MEDIATED IMMUNITY. They are different from the non-hematopoietic FOLLICULAR DENDRITIC CELLS, which have a similar morphology and immune system function, but with respect to humoral immunity (ANTIBODY PRODUCTION). Dendritic Cells, Interdigitating,Interdigitating Cells,Plasmacytoid Dendritic Cells,Veiled Cells,Dendritic Cells, Interstitial,Dendritic Cells, Plasmacytoid,Interdigitating Dendritic Cells,Interstitial Dendritic Cells,Cell, Dendritic,Cell, Interdigitating,Cell, Interdigitating Dendritic,Cell, Interstitial Dendritic,Cell, Plasmacytoid Dendritic,Cell, Veiled,Cells, Dendritic,Cells, Interdigitating,Cells, Interdigitating Dendritic,Cells, Interstitial Dendritic,Cells, Plasmacytoid Dendritic,Cells, Veiled,Dendritic Cell,Dendritic Cell, Interdigitating,Dendritic Cell, Interstitial,Dendritic Cell, Plasmacytoid,Interdigitating Cell,Interdigitating Dendritic Cell,Interstitial Dendritic Cell,Plasmacytoid Dendritic Cell,Veiled Cell
D005456 Fluorescent Dyes Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. Flourescent Agent,Fluorescent Dye,Fluorescent Probe,Fluorescent Probes,Fluorochrome,Fluorochromes,Fluorogenic Substrates,Fluorescence Agents,Fluorescent Agents,Fluorogenic Substrate,Agents, Fluorescence,Agents, Fluorescent,Dyes, Fluorescent,Probes, Fluorescent,Substrates, Fluorogenic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor
D013602 T-Lymphocytes, Cytotoxic Immunized T-lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures (MLC), in vivo during a graft-versus-host (GVH) reaction, or after immunization with an allograft, tumor cell or virally transformed or chemically modified target cell. The lytic phenomenon is sometimes referred to as cell-mediated lympholysis (CML). These CD8-positive cells are distinct from NATURAL KILLER CELLS and NATURAL KILLER T-CELLS. There are two effector phenotypes: TC1 and TC2. Cell-Mediated Lympholytic Cells,Cytotoxic T Cells,Cytotoxic T Lymphocyte,Cytotoxic T-Lymphocytes,TC1 Cell,TC1 Cells,TC2 Cell,TC2 Cells,Cell Mediated Lympholytic Cells,Cell, Cell-Mediated Lympholytic,Cell, TC1,Cell, TC2,Cell-Mediated Lympholytic Cell,Cytotoxic T Cell,Cytotoxic T Lymphocytes,Cytotoxic T-Lymphocyte,Lymphocyte, Cytotoxic T,Lympholytic Cell, Cell-Mediated,Lympholytic Cells, Cell-Mediated,T Cell, Cytotoxic,T Lymphocyte, Cytotoxic,T Lymphocytes, Cytotoxic,T-Lymphocyte, Cytotoxic

Related Publications

Ariadna Mendoza-Naranjo, and Pablo J Saéz, and C Christian Johansson, and Marcos Ramírez, and Dinka Mandakovic, and Cristian Pereda, and Mercedes N López, and Rolf Kiessling, and Juan C Sáez, and Flavio Salazar-Onfray
March 2005, Nature,
Ariadna Mendoza-Naranjo, and Pablo J Saéz, and C Christian Johansson, and Marcos Ramírez, and Dinka Mandakovic, and Cristian Pereda, and Mercedes N López, and Rolf Kiessling, and Juan C Sáez, and Flavio Salazar-Onfray
November 2016, Oncotarget,
Ariadna Mendoza-Naranjo, and Pablo J Saéz, and C Christian Johansson, and Marcos Ramírez, and Dinka Mandakovic, and Cristian Pereda, and Mercedes N López, and Rolf Kiessling, and Juan C Sáez, and Flavio Salazar-Onfray
February 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,
Ariadna Mendoza-Naranjo, and Pablo J Saéz, and C Christian Johansson, and Marcos Ramírez, and Dinka Mandakovic, and Cristian Pereda, and Mercedes N López, and Rolf Kiessling, and Juan C Sáez, and Flavio Salazar-Onfray
June 2016, Neuron,
Ariadna Mendoza-Naranjo, and Pablo J Saéz, and C Christian Johansson, and Marcos Ramírez, and Dinka Mandakovic, and Cristian Pereda, and Mercedes N López, and Rolf Kiessling, and Juan C Sáez, and Flavio Salazar-Onfray
August 2010, Science translational medicine,
Ariadna Mendoza-Naranjo, and Pablo J Saéz, and C Christian Johansson, and Marcos Ramírez, and Dinka Mandakovic, and Cristian Pereda, and Mercedes N López, and Rolf Kiessling, and Juan C Sáez, and Flavio Salazar-Onfray
November 1989, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
Ariadna Mendoza-Naranjo, and Pablo J Saéz, and C Christian Johansson, and Marcos Ramírez, and Dinka Mandakovic, and Cristian Pereda, and Mercedes N López, and Rolf Kiessling, and Juan C Sáez, and Flavio Salazar-Onfray
August 2015, Oncoimmunology,
Ariadna Mendoza-Naranjo, and Pablo J Saéz, and C Christian Johansson, and Marcos Ramírez, and Dinka Mandakovic, and Cristian Pereda, and Mercedes N López, and Rolf Kiessling, and Juan C Sáez, and Flavio Salazar-Onfray
January 1989, Acta morphologica Hungarica,
Ariadna Mendoza-Naranjo, and Pablo J Saéz, and C Christian Johansson, and Marcos Ramírez, and Dinka Mandakovic, and Cristian Pereda, and Mercedes N López, and Rolf Kiessling, and Juan C Sáez, and Flavio Salazar-Onfray
January 2020, Methods in enzymology,
Ariadna Mendoza-Naranjo, and Pablo J Saéz, and C Christian Johansson, and Marcos Ramírez, and Dinka Mandakovic, and Cristian Pereda, and Mercedes N López, and Rolf Kiessling, and Juan C Sáez, and Flavio Salazar-Onfray
December 2008, Blood,
Copied contents to your clipboard!